My dad has sn that’s why his having this how are you
April 28
I thought this medication was to reduce rather than increase certain blood cell production (including platelets).
April 28
That's a very specific question worth exploring! Pegasys (pegylated interferon alfa-2a) is a type of interferon (IFN) therapy. It's currently approved to treat certain types of leukemia, such as chronic myeloid leukemia (CML) and hairy cell leukemia (HCL), but it is not a standard approved treatment for CMML.
Researchers Show Full Answer
That's a very specific question worth exploring! Pegasys (pegylated interferon alfa-2a) is a type of interferon (IFN) therapy. It's currently approved to treat certain types of leukemia, such as chronic myeloid leukemia (CML) and hairy cell leukemia (HCL), but it is not a standard approved treatment for CMML.
Researchers are still studying whether interferon therapy could be beneficial for other leukemia types, so it's possible your doctor is exploring this as part of a clinical trial or off-label use. For CMML-1 specifically, the typical treatment approaches include:
- Chemotherapy to help normalize blood cell counts
- Bone marrow transplant (for eligible patients)
- Supportive care, such as blood transfusions or growth factors to help manage low blood counts, including low platelets (thrombocytopenia)
Low platelet counts are a known concern with CMML and can cause easy bruising and bleeding.
It's really important to have a direct conversation with your oncologist or hematologist about whether Pegasys at 135mcg is appropriate for your specific situation, as treatment plans are highly individual. They'll be best placed to explain the expected benefits and risks for you.
April 28
Join
Your Privacy Choices
